A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

Summary

Lung cancer is one of the most common forms of cancer. One common type is non-small cell lung cancer (NSCLC). NSCLC happens when abnormal cells in the lungs grow too fast. This can stop the lungs from working normally. NSCLC can be divided into types based on where cancer starts. Some NSCLC starts in the cells that line the larger airways near the center of the lungs. This is called squamous NSCLC. Other NSCLC often starts in the outer parts of the lungs, in cells that make mucus. This is called nonsquamous NSCLC. This study focuses on squamous and nonsquamous NSCLC in later stages (advanced).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• IO Resistant Squamous and Nonsquamous NSCLC

Eligibility basics and study details

Study type

Interventional

Phase

Phase 3

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

Takeda

Last updated on ClinicalTrials.gov

November 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites